Turning Complexity into Hope in Honor of My Father
My decision to devote my career to oncology is deeply personal. During my senior year in college, my father was diagnosed with cholangiocarcinoma, or bile duct cancer. As one of his caregivers…
Content with Our Story .
Turning Complexity into Hope in Honor of My Father
My decision to devote my career to oncology is deeply personal. During my senior year in college, my father was diagnosed with cholangiocarcinoma, or bile duct cancer. As one of his caregivers…
Understanding Metastatic Breast Cancer: Exploring the Science
Not all breast cancers are the same. This is particularly true about metastatic breast cancer versus early-stage breast cancer in terms of how the disease spreads, its prognosis, treatment options, and even the patient journey.
Crafting Meaningful Connections to Benefit Patients
Business development is the craft of making connections. Whether with other companies or within our organization, we need to build those bonds that allow us to be successful.
Beyond Positive & Negative: The Spectrum of HER2 Expression in Cancer
Cancer research and development is a dynamic and ever-evolving field. One significant area of focus is the role of HER2.
Daiichi Sankyo’s HER2 Directed ADC Receives Industry’s Top Award
The Galien Foundation has recognized Daiichi Sankyo’s HER2 directed antibody drug conjugate (ADC) with the prestigious 2024 Prix Galien USA Award for Best Biotechnology Product.
The Crafts Driving Our Pipeline Forward—Innovation, Resilience and Leadership
A career of building hope for people with cancer began with a single childhood moment for our Vice President, Global Team Leader, Oncology Research & Development, Dalila Sellami, MD.